Scientists Use Spinach-Derived Photosynthesis to Treat Dry Eye Disease

Researchers have developed a method to induce photosynthesis within the eyes of mice to treat dry eye disease, using a specialized eye drop formulation containing chloroplasts derived from spinach.

The study, reported by Medical Xpress and other science publications, demonstrates a bioengineering approach that essentially turns the ocular surface into a site for light-driven energy production to combat the inflammation and cellular damage associated with dry eye syndrome.

By introducing plant-based organelles into the eye, the scientists were able to produce oxygen locally upon exposure to light, which helped restore the health of the corneal epithelium in the animal models.

This approach addresses a critical challenge in treating dry eye disease, where the lack of adequate lubrication and oxygenation often leads to chronic inflammation and the breakdown of the ocular surface.

Dry eye disease is a multifactorial condition characterized by a loss of homeostasis of the tear film. This can result from either decreased tear production or increased tear evaporation, leading to symptoms of irritation, redness, and blurred vision.

In severe cases, the condition can cause permanent damage to the cornea, the clear front surface of the eye, which can impair sight if left untreated.

The experimental treatment utilizes chloroplasts, the organelles in plant cells that capture light energy to drive the synthesis of food and the release of oxygen.

To make these plant structures compatible with animal biology, the researchers encapsulated the spinach-derived chloroplasts in a protective formulation. This coating prevents the mouse’s immune system from immediately identifying and attacking the foreign plant material while allowing the chloroplasts to remain functionally active.

Once administered as eye drops, these bioengineered structures adhere to the ocular surface. When exposed to light, the chloroplasts perform photosynthesis, generating oxygen and reducing oxidative stress in the surrounding tissues.

The increase in local oxygen levels is particularly significant for the cornea, which is avascular—meaning it lacks blood vessels—and relies primarily on the tear film and the atmosphere for oxygenation.

In the mice treated with the chloroplast formulation, the researchers observed a marked improvement in the regeneration of the corneal epithelium. The light-activated oxygen production appeared to mitigate the inflammatory response and accelerate the healing of the ocular surface.

The use of spinach was selected due to the abundance and stability of its chloroplasts, which can be extracted and maintained in a functional state outside of the plant cell.

This biological integration represents a shift toward using synthetic biology to supplement natural physiological processes. By adding a photosynthetic capability to a non-photosynthetic organ, the researchers created a temporary, light-powered support system for damaged cells.

Current treatments for dry eye disease typically focus on symptom management, such as the use of artificial tears to replace missing lubrication or prescription anti-inflammatory drops to reduce redness, and swelling.

While these treatments provide relief, they often do not address the underlying metabolic deficiency or the oxidative stress that prevents the corneal surface from healing itself.

The bioengineered photosynthesis approach differs by actively providing the metabolic precursors, like oxygen, necessary for cellular repair.

Despite the successful results in mouse models, several hurdles remain before this technology can be applied to human patients.

One primary concern is the long-term biocompatibility of plant organelles in the human eye. While the encapsulation method worked in mice, the human immune system is more complex and may react differently to the spinach-derived proteins over time.

the requirement for light activation means that the efficacy of the treatment would depend on the patient’s exposure to specific wavelengths of light, which may vary based on environment and lifestyle.

The researchers must also determine the optimal dosage and frequency of the eye drops to maintain a therapeutic level of oxygen without causing adverse reactions.

The study highlights a growing trend in regenerative medicine where components from different kingdoms of life—in this case, plants and mammals—are combined to solve medical problems.

If the technology proves safe and effective in humans, it could provide a new therapeutic pathway for patients with chronic ocular surface diseases who do not respond to conventional lubricants or steroid treatments.

Future research will likely focus on optimizing the encapsulation materials to extend the lifespan of the chloroplasts on the eye and testing the treatment across different stages of dry eye severity.